Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PODOFILOX 0.5% TOPICAL SOLN

PODOFILOX
$15.5660per ML

Strength

5 mg/mL

Manufacturer

Padagis US LLC

NDC

00574061105

Classification

Generic

Dosage Form

SOLUTION

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

PODOFILOX

Approval Type

Generic (ANDA)

FDA Application

ANDA075600

On Market Since

1/29/2002

Pharmacological Classes

Decreased Mitosis

Price History

1W

0.0%

1M

+0.3%

3M

-1.2%

6M

-3.7%

1Y

-10.0%

3Y

+26.8%

5Y

+4.9%

All

+9.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00472001304•Actavis Pharma, Inc.
$0.2617
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
62135096841•Chartwell RX LLC
$0.2617
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
69097036108•Cipla USA Inc.
$0.2617
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00713085004•Cosette Pharmaceuticals, Inc.
$0.3348
per ML
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00115172401•Amneal Pharmaceuticals of New York LLC
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00781582701•Sandoz Inc.
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
23155086301•Heritage Pharmaceuticals Inc.
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
42794001308•Sigmapharm Laboratories LLC
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
62135049401•Chartwell RX LLC
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
62135049430•Chartwell RX LLC
$2.9646
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy